AMRX

AMNEAL PHARMACEUTICALS INC

AMRX·03168L105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

AMRX (AMNEAL PHARMACEUTICALS INC) is held by 152 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($304.8M), VANGUARD PORTFOLIO MANAGEMENT LLC ($140.8M), VANGUARD CAPITAL MANAGEMENT LLC ($94.3M). Net institutional sentiment: Mixed.

152
Holders
(12 Elite)
$1.4B
Total Value
63% (160)
Consensus
100 buying - 60 selling
13F: Insider & Congress:
AMRX

Smart Money Verdict

View all
Held by 152 funds
12 elite

Who's Trading

InsiderAMAutor Deborah M.Sell $451KMay 11, 2026
InsiderPGPatel GautamExercise 35K shMay 7, 2026
InsiderMMMEISTER PAUL MExercise 49K shMay 7, 2026
InsiderGPGeorge Jeffrey P.Exercise 35K shMay 7, 2026
InsiderNCNark Ted CExercise 35K shMay 7, 2026
InsiderYSYanai ShlomoExercise 35K shMay 7, 2026
InsiderKJKiely JohnExercise 35K shMay 7, 2026
InsiderAMAutor Deborah M.Exercise 35K shMay 7, 2026
ActivistBlackRock, Inc.BlackRock, Inc.7.6%Apr 27, 2026
ActivistPDPatel Dipan5.4%Mar 26, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
24.5M(+71.5%)$304.8M0.0%+75.06%
46
New
11.3M$140.8M0.0%+35.76%
42
New
7.6M$94.3M0.0%+35.76%
41
Increased
6.8M(+65.3%)$84.5M0.0%+94.86%
44
Increased
5.7M(+1.4%)$70.7M0.0%+221.44%
30
Decreased
4.6M(-3.8%)$57.6M0.0%+92.26%
0
Increased
4.5M(+14.0%)$56.5M0.0%+126.66%
33
Increased
3.7M(+0.7%)$45.7M0.0%+134.49%
29
Increased
3.2M(+0.7%)$40.3M0.0%+110.66%
29
Increased
3.2M(+82.1%)$39.6M0.0%+73.44%
45
Decreased
3.1M(-18.5%)$38.1M0.1%+25.87%
0
Increased
2.9M(+11.0%)$35.6M0.0%+103.48%
32
Increased
2.5M(+72.3%)$32.4M0.1%+56.00%
43
Increased
2.2M(+1.9%)$27.1M0.0%+109.19%
29
Increased
1.9M(+45.4%)$23.2M0.0%+84.88%
39
Decreased
1.7M(-35.4%)$21.4M0.0%+71.98%
0
Increased
1.7M(+10.3%)$21.2M0.0%+85.33%
31
New
1.2M$14.3M0.0%+35.76%
39
Increased
972,529(+527.9%)$12.1M0.0%+45.26%
45
Increased
954,798(+13.5%)$11.9M0.0%+56.02%
32

Showing 1-20 of 168

1 / 9
AMRXAMRXAMNEAL PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used